Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dodge The Fiscal Cliff With Mega-Cap ETFs

Politicians from both sides of the aisle have started to sound a more optimistic tone regarding the chances of avoiding the fiscal cliff. Investors would do well to remember that what politicians say, and what comes to fruition, are often two different things. That and the fiscal cliff, the GDP-sapping scenario in which old tax reductions expire becoming new tax increases, will arrive in January unless a deal is hammered out before year-end.

First Trust Files For Unique Commodity ETF

While there has been no shortage of ideas regarding which stocks and ETFs are to be avoided under the fiscal cliff, one market capitalization spectrum might help investors endure the worst-case scenario: Mega-caps.

There is no hard and fast definition on market value constitutes mega cap, but many analysts and investors believe it is anything north of $100 billion. Running to mega-caps has worked this year. As iShares Global Chief Investment Strategist Russ Koesterich notes, “during the first 10 months of the year, US mega caps gained 13% versus 11.5% for mid caps and 10% for small caps.”

The good news for investors looking to get involved with mega-cap ETF such as the iShares S&P 100 Index (NYSEARCA:OEF) is that, despite the outperformance, mega-caps are still cheaper than large, mid and small-caps, according to Koesterich.

“Currently mega caps are trading at 13x trailing earnings versus 14x for large caps, 18x for mid caps, and nearly 20x for small caps. In addition, mega cap companies remain the most profitable segment of the market, with a return on earnings of 23,” Koesterich wrote in a blog post.

OEF has gained almost 11 percent year-to-date compared to a gain of 10.2 percent for the SPDR S&P 500 (NYSEARCA:SPY). The ETF’s top-five holdings are Apple Inc. (NASDAQ:AAPL), Exxon Mobil Corporation (NYSE:XOM), General Electric Company (NYSE:GE), Microsoft Corporation (NASDAQ:MSFT) and Chevron Corporation (NYSE:CVX).

The more internationally-focused iShares S&P Global 100 Index (NYSEARCA:IOO) has returned 5.4 percent this year. About half of that fund’s country weight is ex-U.S. with the U.K., Switzerland and Germany combing for nearly 30 percent of the ETF’s weight. Exxon, General Electric, Microsoft, Chevron and International Business Machines Corp. (NYSE:IBM) are IOO’s top-five holdings.

“Given the environment, perhaps the most compelling reason to consider an overweight is that mega caps, along with large caps, have historically been more resilient to slowing domestic growth than small and mid cap companies,” wrote Koesterich.

Other mega-cap ETFs to consider include the First Trust Exchange-Traded AlphaDEX Fund (NYSEARCA:FMK). The median market capitalization of FMK’s holdings is $56.7 billion, but the fund looks cheaper on a valuation basis than OEF. OEF has a price-to-earnings ratio of 18.09 and a price-to-book ratio of 4.01. FMK’s P/E is 12.86 and its price-to-book ratio is 1.69, according to First Trust data.

FMK is highly allocated to discretionary names as Ford Motor Company (NYSE:F), Comcast Corporation (NASDAQ:CMCSA) and The Home Depot, Inc. (NYSE:HD) are the fund’s top-three holdings. Overall, the discretionary sector accounts for almost a quarter of FMK’s weight.

The Rydex Russell Top 50 (NYSEARCA:XLG) should note be overlooked, either. XLG tracks the Russell Top 50 Index and has gained 10.9 percent this year, meaning of the ETFs highlighted here, XLG is the second-best performer behind only OEF.

This article was originally written by The ETF Professor, and posted on Benzinga.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!